Market Research Future (MRFR) has published a cooked research report on the “Global Varicose veins treatment devices market” that contains information from 2018 to 2032. The Varicose veins treatment devices market is estimated to register a CAGR of 7.20% during the forecast period of 2023 to 2032.
MRFR recognizes the following companies as the key players in the global Varicose veins treatment devices market— Angio Dynamics, Medtronic, Teleflex Incorporated, Sciton Inc., Dornier Medtech, Merit Medical Systems, Alma Lasers, Biolitec AG, Boston Scientific Corporation and others
The global varicose veins treatment devices market is accounted to register a CAGR of 7.20% during the forecast period and is estimated to reach USD 2.24 Billion by 2032.
The varicose veins treatment devices market targets medical solutions for varicose and spider veins. It includes devices such as laser systems, catheters, and compression stockings that aid in minimally invasive treatments. This market addresses the growing demand for effective and less invasive solutions for venous health issues.
The global varicose veins treatment devices market has been segmented based type and end use.
On the basis of type, the market is segmented into endovenous ablation, sclerotherapy and surgical ligation & stripping. The endovenous ablation segment dominated the market in 2022. Endovenous ablation techniques are less invasive than conventional surgical procedures for treating varicose veins.
Based on end use, the global varicose veins treatment devices market has been segmented into vein clinics, hospitals and ambulatory care unit. The hospitals category generated the most income in 2022. By offering a wide range of services under one roof, hospitals serve as hubs for comprehensive healthcare.
Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Varicose Veins Treatment Devices Market Research Report
The global varicose veins treatment devices market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Varicose veins treatment devices market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Varicose veins treatment devices market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Varicose veins treatment devices market comprises of Middle East, Africa, and Latin America.
The North America varicose veins treatment devices market dominated this market in 2022 (45.80%). Modern medical facilities, including cutting-edge hospitals, specialized clinics, and contemporary medical facilities, are proudly displayed throughout the region. This infrastructure supports the adoption of sophisticated treatment techniques, such as minimally invasive procedures made feasible by varicose vein therapy devices.
Moreover, the Europe market has been persistently growing over the forecast period. European regulatory authorities place the highest premium on patient safety and product quality. Devices that follow tight regulatory requirements are more likely to be trusted by medical professionals and patients, which aids in their commercialization.
The Asia-Pacific varicose veins treatment devices market is expected to grow at the fastest CAGR from 2023 to 2032. Many Asia-Pacific countries have made significant investments in their healthcare infrastructure. As medical facilities advance and access to healthcare services increases, there is a growing demand for cutting-edge treatment options like varicose vein treatment devices.
Furthermore, the rest of the world's varicose veins treatment devices market is divided into the Middle East, Africa, and Latin America. The Latin American varicose veins treatment devices market addresses medical interventions for venous issues. This includes devices like laser systems and compression stockings, offering minimally invasive solutions. The market supports healthcare by providing technologies that aid in effective varicose vein treatment across the region.
Key Findings of the Study